Healthcare News and Research

Latest Healthcare News and Research

Technique for developing more targeted drugs using molecular "robots"

Many drugs such as agents for cancer or autoimmune diseases have nasty side effects because while they kill disease-causing cells, they also affect healthy cells. Now a new study has demonstrated a technique for developing more targeted drugs, by using molecular "robots" to hone in on more specific populations of cells.

29 Jul 2013

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy

26 Jul 2013

First Edition: July 26, 2013

Today's headlines include reports about an effort by some GOP lawmakers to force a showdown over health law funding.

26 Jul 2013

Gout, uric acid levels and risk of death: an interview with Professor Austin Stack, Graduate Entry Medical School, University of Limerick

Gout is a relatively common arthritic disease that affects about 4% (I in 25) of the population. It results from the deposition of uric acid in joints due to elevated blood levels and a resulting inflammation ensues which is very painful.

26 Jul 2013

Columbia Laboratories’ Board of Directors set a ratio of 1-for-8 for its reverse stock split

Columbia Laboratories, Inc. ("Columbia" or the "Company") (NasdaqCM: CBRX) announced today that its Board of Directors (the "Board") has set a ratio of 1-for-8 for its previously approved reverse stock split of its common stock, and an anticipated effective date for the reverse stock split of the later of (i) the filing with the Secretary of the State of Delaware of a certificate of amendment with respect to the reverse stock split or (ii) August 9, 2013.

26 Jul 2013

Piramal's Healthcare invests USD 2.5 million to upgrade ADC manufacturing suites

Piramal's Healthcare vertical today announced that it is to invest USD 2.5 million at its FDA approved Grangemouth, UK, site to upgrade one of its antibody drug conjugate (ADC) manufacturing suites, from clinical phase to commercial grade, in response to customer demand.

26 Jul 2013

Compliance leaders give insight and thoughts in new ebook

Regulatory non compliance costs the pharma industry billions in fines, audits and much more each year. To avoid these fines and bad reputation pharma companies rely heavily on their compliance teams, who provide oversight from R&D to the very end of a product cycle.

26 Jul 2013

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

26 Jul 2013

GAO analysis: Health premiums vary widely

The Government Accountability Office report, which is based on prices reported by insurers, shows that consumers face a wide range of premium prices, deductibles and annual exposure to out-of-pocket costs.

26 Jul 2013

Journal of Racial and Ethnic Health Disparities to address crucial healthcare problem in US

Springer has entered into an agreement with the W. Montague Cobb/National Medical Association (NMA) Health Institute to publish the Journal of Racial and Ethnic Health Disparities. Starting in 2014 the new society journal will be published quarterly, electronically on link.springer.com and in print.

26 Jul 2013

Zydus, IDRI partner to develop visceral leishmaniasis vaccine candidate

In a unique partnership, Zydus, India's fourth largest healthcare group and an innovation-led global healthcare provider, and IDRI, a Seattle-based non-profit research and product development organization, announced today they are collaborating on the production and clinical development of IDRI's visceral leishmaniasis vaccine candidate, designed to prevent the deadly parasitic disease.

26 Jul 2013

Frequency, duration of patient-doctor contact important for improving health of dialysis patients

Both the frequency and duration of patient-doctor contact during dialysis care vary appreciably across countries, and facilities with more frequent and longer contact had fewer patient deaths and hospitalizations, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

26 Jul 2013

For many states, Medicaid expansion plans remain unsettled

Federal officials remind Florida lawmakers that it is not too late to opt into the program, while in Virginia, Politico reports the issue could be decided by this fall's gubernatorial election. Also, an Arizona push to get the issue on the ballot in November may fail because of paperwork errors and the Michigan Senate considers a tweaked expansion bill that requires co-pays for new Medicaid enrollees.

26 Jul 2013

Abbott's FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System gets FDA clearance

Abbott today announced that it has received U.S. Food and Drug Administration clearance for its FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System, an advanced blood glucose monitoring system designed to address the key needs of hospital customers: high accuracy, efficient operation, dual-band wireless access to immediate test results, and helps in the reduction of the risk of test strip cross-contamination.

26 Jul 2013

IOM urges Congress not to shift Medicare payments to pay more in areas with low costs

A panel of experts says the government should by wary of suggestions that cutting payments to high cost areas and rewarding low-cost areas would help improve care and reduce Medicare costs.

26 Jul 2013

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

Sanofi Pasteur, the vaccines division of Sanofi, announced today that the first lots of Fluzone (Influenza Virus Vaccine) for the 2013-2014 season have been released by the U.S. Food and Drug Administration for U.S. distribution and were shipped July 24.

25 Jul 2013

Ascendancy Healthcare signs multi-year collaboration with Quintiles

Ascendancy Healthcare, Inc. dedicated to the commercialization of therapeutic products to meet unmet medical needs in China and other high-growth Asian markets, announced today a multi-year collaboration with Quintiles, the world's largest provider of biopharmaceutical development and commercial outsourcing services.

25 Jul 2013

Healthcare News and Research

Latest Healthcare News and Research

Technique for developing more targeted drugs using molecular "robots"

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

First Edition: July 26, 2013

Gout, uric acid levels and risk of death: an interview with Professor Austin Stack, Graduate Entry Medical School, University of Limerick

Columbia Laboratories’ Board of Directors set a ratio of 1-for-8 for its reverse stock split

Piramal's Healthcare invests USD 2.5 million to upgrade ADC manufacturing suites

Compliance leaders give insight and thoughts in new ebook

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

GAO analysis: Health premiums vary widely

Journal of Racial and Ethnic Health Disparities to address crucial healthcare problem in US

Zydus, IDRI partner to develop visceral leishmaniasis vaccine candidate

Frequency, duration of patient-doctor contact important for improving health of dialysis patients

For many states, Medicaid expansion plans remain unsettled

Abbott's FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System gets FDA clearance

IOM urges Congress not to shift Medicare payments to pay more in areas with low costs

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

Ascendancy Healthcare signs multi-year collaboration with Quintiles

NxStage Medical revenue increases 11% to $65.5 million in Q2 2013

Teleflex introduces Rusch TruLite Laryngoscope System

First Edition: July 25, 2013

Event guide: 3rd Measuring Patient Engagement Summit eBook

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Healthcare News and Research

Latest Healthcare News and Research

Event guide: 3rd Measuring Patient Engagement Summit eBook

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Newsletters you may be interested in